AGMB AGOMAB THERAPEUTICS NV
FollowSPONSORED ADS (ADR), issuer CIK 2020932
34 managers (34 13F filers) reported a position in AGMB shares at 2026-06-30, 25,955,482 shares in all. 9 filers opened a position and 7 filers sold out during the quarter.
- Managers
- 34
- 13F filers
- 34
- New
- 9
- Added
- 4
- Reduced
- 6
- Sold out
- 7
- Shares held by filers
- 25,955,482
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Redmile Group, LLC(group Redmile Group, LLC)
1,740,230 shares, 3.5% in a 13G/A as of 2026-09-30,0000905148-26-004929
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Epstein David Rdirector | 2026-11-17 | +5,000 P | $5.57 | Form 4 |
| Epstein David Rdirector | 2026-11-13 | +4,960 P | $6.02 | Form 4 |
| Epstein David Rdirector | 2026-11-13 | +5,000 P | $5.75 | Form 4 |
| Epstein David Rdirector | 2026-11-13 | +20 P | $6 | Form 4 |
| Epstein David Rdirector | 2026-11-13 | +5,000 P | $5.99 | Form 4 |
| Epstein David Rdirector | 2026-11-05 | +5,000 P | $6.98 | Form 4 |
| Epstein David Rdirector | 2026-11-05 | +5,000 P | $6.91 | Form 4 |
| Epstein David Rdirector | 2026-11-05 | +5,000 P | $6.81 | Form 4 |
| Epstein David Rdirector | 2026-10-21 | +5,000 P | $8.9 | Form 4 |
| Epstein David Rdirector | 2026-10-21 | +5,000 P | $8.86 | Form 4 |
| Epstein David Rdirector | 2026-10-08 | +5,000 P | $8.9 | Form 4 |
| Epstein David Rdirector | 2026-10-06 | +5,000 P | $8.7 | Form 4 |
| Kemula Pierre Thadee Victorofficer (Chief Financial Officer) | 2026-10-06 | +2,000 P | $8.54 | Form 4 |
| Kemula Pierre Thadee Victorofficer (Chief Financial Officer) | 2026-10-06 | +5,000 P | $8.57 | Form 4 |
| Kemula Pierre Thadee Victorofficer (Chief Financial Officer) | 2026-10-06 | +3,000 P | $8.67 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5,141,992 | $66.7M | 7.74% | 0 | 13F-HRTimeline |
| Sanofi | 2,783,096 | $36.1M | 6.76% | 0 | 13F-HRTimeline |
| Redmile Group, LLCin group Redmile Group, LLC | 2,733,926 | $35.5M | 2.38% | +2,577,676 | 13F-HRTimelineGroup |
| Cormorant Asset Management, LPin group Cormorant Asset Management, LP | 2,465,348 | $32M | 1.64% | 0 | 13F-HRTimelineGroup |
| TCG Crossover Management, LLC | 2,053,233 | $26.7M | 0.64% | 0 | 13F-HRTimeline |
| FEDERATED HERMES, INC.in group FEDERATED HERMES, INC. | 1,618,000 | $21M | 0.03% | 0 | 13F-HRTimelineGroup |
| Nantahala Capital Management, LLCin group Nantahala Capital Management,… | 1,568,188 | $20.4M | 1.23% | +368,188 | 13F-HR/ATimelineGroup |
| Casdin Capital, LLC | 1,550,000 | $20.1M | 1.01% | 0 | 13F-HRTimeline |
| ANDERA PARTNERSin group ANDERA PARTNERS | 1,538,702 | $20M | 9.67% | 0 | 13F-HRTimelineGroup |
| FMR LLCin group FMR LLC | 1,458,677 | $18.9M | <0.01% | 0 | 13F-HRTimelineGroup |
| Aberdeen Group plcin group Aberdeen Group plc | 846,695 | $11M | 0.02% | +139,039 | 13F-HRTimelineGroup |
| PERCEPTIVE ADVISORS LLCin group PERCEPTIVE ADVISORS LLC | 600,000 | $7.79M | 0.12% | 0 | 13F-HRTimelineGroup |
| SAMSARA BIOCAPITAL, LLC | 600,000 | $7.79M | 0.64% | 0 | 13F-HRTimeline |
| Siren, L.L.C.in group Siren, L.L.C. | 411,250 | $5.34M | 0.11% | 0 | 13F-HRTimelineGroup |
| ORBIMED ADVISORS LLCin group ORBIMED ADVISORS LLC | 192,740 | $2.5M | 0.05% | new | 13F-HRTimelineGroup |
| Pfizer Incin group Pfizer Inc | 75,000 | $1.04M | 0.61% | 0 | 13F-HRTimelineGroup |
| ALPS ADVISORS INCin group ALPS ADVISORS INC | 49,984 | $649K | <0.01% | new | 13F-HRTimelineGroup |
| Bellevue Group AGin group Bellevue Group AG | 49,248 | $639K | 0.01% | -752 | 13F-HRTimelineGroup |
| SEVEN GRAND MANAGERS, LLC | 47,600 | $618K | 0.02% | -152,400 | 13F-HRTimeline |
| SECTORAL ASSET MANAGEMENT INC | 43,500 | $565K | 0.39% | 0 | 13F-HRTimeline |
| Burkehill Global Management, LP | 35,000 | $454K | 0.02% | 0 | 13F-HRTimeline |
| Quadrature Capital Ltdin group Quadrature Capital Ltd | 20,461 | $266K | <0.01% | new | 13F-HRTimelineGroup |
| TWO SIGMA INVESTMENTS, LPin group TWO SIGMA INVESTMENTS, LP | 18,072 | $235K | <0.01% | +3,831 | 13F-HRTimelineGroup |
| HRT FINANCIAL LP | 17,075 | $221K | <0.01% | -6,651 | 13F-HRTimeline |
| GOLDMAN SACHS GROUP INCin group GOLDMAN SACHS GROUP INC | 11,800 | $153K | <0.01% | -23,939 | 13F-HRTimelineGroup |
| XTX Topco Ltdin group XTX Topco Ltd | 10,271 | $133K | <0.01% | new | 13F-HRTimelineGroup |
| CITIGROUP INCin group CITIGROUP INC | 9,496 | $123K | <0.01% | new | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 2,128 | $27.6K | <0.01% | -4,309 | 13F-HRTimelineGroup |
| GAMMA Investing LLC | 1,344 | $17.4K | <0.01% | new | 13F-HRTimeline |
| MORGAN STANLEYin group MORGAN STANLEY | 1,200 | $15.6K | <0.01% | -1,825 | 13F-HRTimelineGroup |
| BNP PARIBAS FINANCIAL MARKETSin group BNP PARIBAS FINANCIAL MARKETS | 754 | $9.79K | <0.01% | new | 13F-HRTimelineGroup |
| Larson Financial Group LLC | 698 | $9.06K | <0.01% | new | 13F-HRTimeline |
| SBI Securities Co., Ltd. | 2 | $26 | <0.01% | 0 | 13F-HRTimeline |
| Caitong International Asset Management … | 2 | $26 | <0.01% | new | 13F-HRTimeline |
Events
Epstein David R bought 5,000 AGMB shares on 2026-11-17, Form 4 filed 2026-11-19. 0001445826-26-000020
Accepted , ingestedRedmile Group, LLC and 2 other reporting persons reported 1,740,230 AGMB shares, 3.5% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0000905148-26-004929
Accepted , ingestedEpstein David R bought 14,980 AGMB shares on 2026-11-13, Form 4 filed 2026-11-16. 0001445826-26-000019
Accepted , ingestedEpstein David R bought 15,000 AGMB shares on 2026-11-05, Form 4 filed 2026-11-06. 0001445826-26-000018
Accepted , ingestedEpstein David R bought 10,000 AGMB shares on 2026-10-21, Form 4 filed 2026-10-22. 0001445826-26-000015
Accepted , ingestedEpstein David R bought 5,000 AGMB shares on 2026-10-08, Form 4 filed 2026-10-09. 0001445826-26-000014
Accepted , ingestedEpstein David R bought 10,000 AGMB shares between 2026-10-05 and 2026-10-06, Form 4 filed 2026-10-07. 0001445826-26-000013
Accepted , ingestedKemula Pierre Thadee Victor bought 10,000 AGMB shares on 2026-10-06, Form 4 filed 2026-10-07. 0002119332-26-000001
Accepted , ingestedKnotnerus Tim Jasper bought 11,000 AGMB shares between 2026-10-05 and 2026-10-06, Form 4 filed 2026-10-07. 0002120886-26-000001
Accepted , ingested